Seasonal, avian, and novel H1N1 influenza: Prevention and treatment modalities

Annals of Pharmacotherapy

Volumn 43, Issue 12, 2009, Pages 2001-2011

  Sym, Donna ^a,b   Patel, Priti N ^a   El Chaar, Gladys M ^a,c  

^a ST JOHN'S UNIVERSITY   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c Schneider Childrens Hospital   (United States)

Author keywords

Avian influenza; H1N1; H3N2; H5N1; Seasonal influenza; Swine influenza

Indexed keywords

ADAMANTANE DERIVATIVE; AMANTADINE; ANTIVIRUS AGENT; FLULAVAL; INACTIVATED VACCINE; INFLUENZA VACCINE; LIVE VACCINE; OSELTAMIVIR; RIBAVIRIN; RIMANTADINE; SIALIDASE INHIBITOR; TRIPLE VACCINE; UNCLASSIFIED DRUG; ZANAMIVIR;

ANTIBIOTIC RESISTANCE; ANTIVIRAL ACTIVITY; AVIAN INFLUENZA; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG MECHANISM; DRUG MEGADOSE; EPIDEMIC; FOWL; HIGH RISK POPULATION; HOST; HUMAN; IMMUNITY; IMMUNIZATION; INFECTION CONTROL; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H2N2; INFLUENZA VIRUS A H3N2; NEUROTOXICITY; PANDEMIC; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SEASONAL VARIATION; SWINE; SWINE INFLUENZA; SWINE INFUENZA; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTIVIRAL AGENTS; BIRDS; COMMUNICABLE DISEASE CONTROL; DISEASE OUTBREAKS; DRUG RESISTANCE, VIRAL; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; INFLUENZA, HUMAN; SWINE;

EID: 72249098534     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1M557     Document Type: Review

References (73)

1. Monto AS. The risk of seasonal and pandemic influenza: prospects for control. Clin Infect Dis 2009;48:S20-5.
2. Webster RG, Peiris M, Chen H, Guan Y. H5N1 outbreaks and enzootic influenza. Emerg Infect Dis 2006;12:3-8.
3. Luke CJ, Subbaro K. Vaccines for pandemic influenza. Emerg Infect Dis 2006;12:66-72.
4. Centers for Disease Control and Prevention. Key facts about swine influenza (swine flu). www.cdc.gov/flu/swineflu/key-facts.htm (accessed 2009 Sept 15).
5. Centers for Disease Control and Prevention. Novel H1N1 flu: background on the situation. www.cdc.gov/h1n1flu/background.htm (accessed 2009 Sept 15).
6. Ward P, Small I, Smith J, et al. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 2005;55(S1):i5-21. (Pubitemid 40331165)
7. Lamontagne JR. Summary of a workshop on influenza B viruses and Reye's Syndrome. J Infect Dis 1980;142:452-465 (Pubitemid 10024587)
8. Stiver G. The treatment of influenza with antiviral drugs. CMAJ 2003;168:49-57.
9. Potter CW. A history of influenza. J Applied Microbiol 2001;91:572-579
10. Stiver GH. The threat and prospects for control of an influenza pandemic. Exp Rev Vaccines 2004;3:35-42. (Pubitemid 38196954)
11. Groeneveld K, van der Noordaa J. Use of antiviral agents and other measures in an influenza pandemic. Neth J Med 2005;63:339-343 (Pubitemid 41748587)
12. Belshe ARB. The origins of pandemic influenza - lessons from the 1918 virus. N Engl J Med 2005;353:2209-2211
13. Trilla A, Trilla G, Daer C. The 1918 "Spanish flu" in Spain. Clin Infect Dis 2008;47:668-673
14. Chan PKS. Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis 2002;34(suppl 2):S58-64.
15. Taubenberger JK. Hultin JV, Morens DM. Discovery and characterization of the 1918 pandemic influenza virus in historical context. Antivir Ther 2007;12:581-591
16. Chotpitayasunondh T, Ungchusak K, Hanshaoworakul W, et al. Human disease from influenza A (H1N1), Thailand, 2004. Emerg Infect Dis 2005;11:201-209
17. Subbarao K, Klimov A, Katz J, et al. Characterization of an avian influenza A (H1N1) virus isolated from a child with a fatal respiratory illness. Science 1998;279:393-396 (Pubitemid 28063376)
18. Peiris JSM, Yu WC, Leung CW. Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004;363:617-619
19. Ungchusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (H5N1). N Engl J Med 2005;352:333-340
20. Bridges CB, Katz JM, Seto W, et al. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. J Infect Dis 2000;181:344-348 (Pubitemid 30049068)
21. Katz JM, Lim W, Bridges CB, et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis 1999;180:1763-1770
22. Kandun IN, Wibisono H, Sedyaningsih ER, et al. Three Indonesian clusters of H5N1 virus infection in 2005. N Engl J Med 2006;355:2186-2194 (Pubitemid 44791160)
23. Shinya K, Ebina M, Yamada S, et al. Influenza virus receptors in the human airway. Nature 2006;440:435-436
24. van Riel D, Munster VJ, de Wit E, et al. H5N1 virus attachment to lower respiratory tract. Sci Mag 2009;312:399.
25. World Health Organization. Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO. www.who.int/csr/ disease/avian- influenza/country/cases-table-2009-09-24/en/index.html (accessed 2009 Oct 12).
26. Dowdle WR, Hattwick MA. Swine influenza virus infections in humans. J Infect Dis 1976;136:S386-9.
27. Gatherer D. The 2009 H1N1 influenza outbreak in its historical context. J Clin Virol 2009;45:174-178
28. Shinde V, Bridges CB, Uyeki TM, et al. Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med 2009;360:2616-2625
29. Peiris JSM, Poon LLM, Guan Y. Emergence of a novel swine-origin influenza A virus (S-OIV) H1N1 virus in humans. J Clin Virol 2009;45:169-173
30. Gaydos JC, Hodder RA, Top FH. Swine influenza A at Fort Dix, New Jersey (January-February 1976). II. Transmission and morbidity in units with cases. J Infect Dis 1977;136:S363-8.
31. Myers KP, Olsen CW, Gray GC. Cases of swine influenza in humans: a review of the literature. Clin Infect Dis 2007;44:1084-1088 (Pubitemid 46580277)
32. Kendal AP, Goldfield M, Noble GR, Dowdle WR. Identification and preliminary antigenic analysis of swine influenza-like viruses isolated during an influenza outbreak at Fort Dix, New Jersey. J Infect Dis 1977;136:S381-5.
33. Neumann G, Noda T, Kawaoka Y. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 2009;459:931-939
34. Han K, Zhu X, Liu L, et al. Lack of airborne transmission during outbreak of pandemic (H1N1) 2009 among tour group members, China, June 2009. Emerg Infect Dis 2009;15:1578-1581
35. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615
36. World Health Organization. Pandemic (H1N1) 2009-update 69. www.who.int/csr/don/2009-10-09/en/index.html (accessed 2009 Oct 12).
37. Centers for Disease Control and Prevention. 2008-2009 influenza season week 39 ending October 3, 2009. www.cdc.gov/flu/weekly/ (accessed 2009 Oct 12).
38. Centers for Disease Control and Prevention. Influenza symptoms and laboratory diagnostic procedures. www.cdc.gov/flu/professionals/diagnosis/ Labprocedures.htm (accessed 2009 Sept 15).
39. Centers for Disease Control and Prevention. Clinical signs and symptoms of influenza. www.cdc.gov/flu/professionals/acip/clinical.htm (accessed 2009 Sept 15).
40. World Health Organization. WHO rapid advice guidelines on pharmacological management of humans infected with avian influenza A (H5N1) virus. www.who.int/medicines/publications/WHO-PSM-PAR-2006.6.pdf (accessed 2009 Sept 15).
41. Centers for Disease Control and Prevention. Avian influenza A virus infections of humans. www.cdc.gov/flu/avian/gen-info/avian-flu-humans.htm (accessed 2009 Sept 15).
42. Uyeki TM. Human infection with highly pathogenic avian influenza A (H5N1) virus: review of clinical issues. Clin Infect Dis 2009;49:279-290
43. Hui DS. Review of clinical symptoms and spectrum in humans with influenza AH/H5N1 infection. Respirology 2008;13(suppl 1):S10-3.
44. Centers for Disease Control and Prevention. Interim guidance for clinicians on identifying and caring for patients with swine-origin influenza A (H1N1) virus infection. www.cdc.gov/h1n1flu/identifyingpatients.htm (accessed 2009 Sept 15).
45. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines. MMWR Morb Mortal Wkly Rep 2009;58:1-52.
46. Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. MMWR Morb Mortal Wkly Rep 2009;58:1-8.
47. Centers for Disease Control and Prevention. Update on influenza A (H1N1) 2009 monovalent vaccines. MMWR Morb Mortal Wkly Rep 2009;58:1100-1101
48. Prescribing information. Influenza A (H1N1) monovalent vaccine. Swiftwater, PA: Sanofi Pasteur, Inc., September 2009.
49. Prescribing information. Influenza A (H1N1) monovalent vaccine. Cambridge, MA: Novartis Vaccines and Diagnostics, Inc., September 2009.
50. Prescribing information. Influenza A (H1N1) monovalent vaccine. King of Prussia, PA: CSL Limited, September 2009.
51. Prescribing information. Influenza A (H1N1) monovalent vaccine, live intranasal. Gaithersburg, MD: Medimmune, LLC., September 2009.
52. Food and Drug Administration. H5N1 influenza virus vaccine questions and answers. www.fda.gov/BiologicsBloodVaccines/Vaccines/Questions aboutVaccines/ucm080753.htm (accessed 2009 Sept 15).
53. De Jong MD, Hien TT. Avian influenza A (H5N1). J Clin Virol 2006;35: 2-13.
54. McNicholl IR, McNicholl JJ. Neuraminidase inhibitors: zanamivir and oseltamivir. Ann Pharmacother 2001;35:57-70. DOI 10.1345/aph.10118
55. Moscona A. Neuraminidase inhibitors for influenza. N Engl J Med 2005;353:1363-1373
56. Cheer SM, Wagstaff AJ. Zanamivir. Drugs 2002;62:71-106.
57. Schmidt AC. Antiviral therapy for influenza: a clinical and economic comparative review. Drugs 2004;64:2031-2046
58. Centers for Disease Control and Prevention. Updated interim recommendations for the use of antiviral medications in the treatment and prevention of influenza for the 2009-2010 season. www.cdc.gov/h1n1flu/ recommendations.htm (accessed 2009 Sept 15).
59. Centers for Disease Control and Prevention. Interim recommendations for the use of influenza antiviral medications in the setting of oseltamivir resistance among circulating influenza A (H1N1) viruses, 2008-09 influenza season. www.cdc.gov/flu/professionals/antivirals/recommendations.htm (accessed 2009 Sept 15).
60. Centers for Disease Control and Prevention. Considerations regarding novel H1N1 flu virus in obstetric settings. www.cdc.gov/h1n1flu/guidance/ obstetric.htm (accessed 2009 Sept 15).
61. Centers for Disease Control and Prevention. Emergency use authorization for peramivir IV. www.cdc.gov/h1n1flu/eua/peramivir.htm. (accessed 2009 Nov 5).
62. World Health Organization. Clinical management of human infection with avian influenza A (H5N1) virus. www.who.int/csr/disease/avian-influenza/ guidelines/ClinicalManagement07.pdf (accessed 2009 Sept 1).
63. Gambotto A, Barratt-Boyes SM, de Jong MD, et al. Human infection with highly pathogenic H5N1 influenza virus. Lancet 2008;371:1464-1475 (Pubitemid 351618340)
64. Furuse Y, Suzuki A, Oshitani H. Large-scale sequence analysis of M gene of influenza A viruses from different species: mechanisms for emergence and spread of amantadine resistance. Antimicrob Agents Chemother 2009;53:4457-4463
65. Dharan NJ, Gubareva LV, Meyer JJ, et al. Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States. JAMA 2009;301:1034-1041
66. Poland GA, Jacobson RM, Ovsyannikova IG. Influenza virus resistance to antiviral agents: a plea for rational use. Clin Infect Dis 2009;48:1254-1256
67. Centers for Disease Control and Prevention. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis - North Carolina, 2009. MMWR Morb Mortal Wkly Rep 2009;58:969-972
68. Moscona A. Oseltamivir resistance disabling our influenza defenses. N Engl J Med 2005;353:2633-2636 (Pubitemid 41817709)
69. Centers for Disease Control and Prevention. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb Mortal Wkly Rep 2009;58(dispatch):1-4.
70. Hurt AC, Holien JK, Parker M, et al. Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol 2009;83:10366-10373
71. Federal Emergency Management Agency. Emergency assistance for human influenza pandemic. www.fema.gov/government/grant/pa/9523-17. shtm (accessed 2009 Oct 15).
72. The Washington Post. Antiviral stockpiles. www.washingtonpost.com/wpdyn/ content/graphic/2009/05/01/GR2009050100352.html (accessed 2009 Oct 15).
73. The Washington Post. School shut by flu can reopen. www.washingtonpost. com/wp-dyn/content/article/2009/05/05/AR2009050500719.html (accessed 2009 Oct 15).